Montreal—Compared with the use of volatile anesthetics, total IV anesthesia (TIVA) may offer long-term protective effects following breast cancer surgery.
A new systematic review and meta-analysis concluded that patients undergoing TIVA with propofol had lower rates of cancer recurrence and higher rates of recurrence-free survival. However, there was no significant difference between groups in overall mortality.
“The impetus for this meta-analysis was to look at differences in